Dockery, L., Gunderson, C., & Moore, K. (2017). Rucaparib: The past, present, and future of a newly approved PARP inhibitor for ovarian cancer. Onco Targets Ther.
Chicago ZitierstilDockery, LE, CC Gunderson, und KN Moore. "Rucaparib: The Past, Present, and Future of a Newly Approved PARP Inhibitor for Ovarian Cancer." Onco Targets Ther 2017.
MLA ZitierstilDockery, LE, CC Gunderson, und KN Moore. "Rucaparib: The Past, Present, and Future of a Newly Approved PARP Inhibitor for Ovarian Cancer." Onco Targets Ther 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.